| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,309 |
14,185 |
$2.47M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,443 |
11,040 |
$2.23M |
| H2015 |
Comprehensive community support services, per 15 minutes |
10,292 |
4,143 |
$1.80M |
| 90834 |
Psychotherapy, 45 minutes with patient |
8,519 |
6,700 |
$1.49M |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,231 |
2,599 |
$571K |
| 90791 |
Psychiatric diagnostic evaluation |
2,972 |
2,953 |
$516K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,750 |
2,238 |
$481K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,582 |
1,100 |
$458K |
| H2017 |
Psychosocial rehabilitation services, per 15 minutes |
998 |
179 |
$166K |
| Q3014 |
Telehealth originating site facility fee |
6,932 |
6,349 |
$141K |
| 99441 |
|
751 |
677 |
$129K |
| 99442 |
|
744 |
668 |
$128K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
746 |
702 |
$124K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
553 |
541 |
$99K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
421 |
412 |
$66K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,652 |
1,158 |
$49K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
188 |
188 |
$31K |
| H2011 |
Crisis intervention service, per 15 minutes |
134 |
129 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
67 |
66 |
$11K |
| 0012A |
|
37 |
36 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
659 |
645 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
87 |
84 |
$5K |
| 0011A |
|
29 |
29 |
$5K |
| 87428 |
|
155 |
151 |
$4K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
22 |
16 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
895 |
873 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
282 |
277 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
16 |
$3K |
| 99443 |
|
15 |
14 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$2K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
63 |
45 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
12 |
$2K |
| 99215 |
Prolong outpt/office vis |
15 |
14 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
452 |
448 |
$2K |
| 99173 |
|
59 |
59 |
$777.56 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
106 |
71 |
$570.56 |
| 86703 |
|
30 |
30 |
$538.86 |
| 90715 |
|
100 |
100 |
$520.10 |
| 90688 |
|
169 |
169 |
$347.68 |
| 90686 |
|
45 |
44 |
$186.43 |
| 80061 |
Lipid panel |
165 |
164 |
$183.39 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
13 |
$166.64 |
| 36416 |
|
258 |
252 |
$51.12 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
15 |
$0.00 |
| 81002 |
|
12 |
12 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
177 |
177 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
27 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
322 |
318 |
$0.00 |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
29 |
26 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
64 |
62 |
$0.00 |
| 81001 |
|
25 |
25 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15 |
15 |
$0.00 |